98 related articles for article (PubMed ID: 1811226)
1. [PAF-antagonists with phospholipid structure. 3. Phospholipids with heterocyclane head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationship].
Kertscher HP; Ostermann G
Pharmazie; 1991 Nov; 46(11):772-4. PubMed ID: 1811226
[TBL] [Abstract][Full Text] [Related]
2. [PAF-antagonists with phospholipid structure. 2. Phospholipids with heteroarene head groups and variations of the phosphorus-nitrogen distance; synthesis, characterization and structure-activity relationships].
Kertscher HP; Ostermann G
Pharmazie; 1991 Oct; 46(10):708-11. PubMed ID: 1803385
[TBL] [Abstract][Full Text] [Related]
3. [PAF-antagonists with phospholipid structure. 4. Alkylcarbamoylphospholipids with heteroarene and heterocyclase head groups and variation of the P-N-distance; synthesis, characterization and structure-activity relationship].
Kertscher HP; Schmidt B; Ostermann G
Pharmazie; 1992 Mar; 47(3):172-4. PubMed ID: 1615020
[TBL] [Abstract][Full Text] [Related]
4. [PAF-antagonists with a phospholipid structure. 5. Propanediol phospholipids with various substituted pyridinium and quinuclidinium head groups and variations of the phosphorus-nitrogen distance;synthesis, characterization and structure activity relationship].
Kertscher HP; Schwabe W; Grupe R
Pharmazie; 1993 Jan; 48(1):23-6. PubMed ID: 8460172
[TBL] [Abstract][Full Text] [Related]
5. [PAF-antagonists with lipid structure. 6. Alkylpropandiol lipids with acyl- and ether- structures at the C-3 position and heterocyclic head groups; synthesis, characterization and structure-activity relationship].
Kertscher HP
Pharmazie; 1997 Sep; 52(9):672-5. PubMed ID: 9411454
[TBL] [Abstract][Full Text] [Related]
6. [PAF-antagonists with a phospholipid structure. 1. Phospholipids with hetero-arene head groups: synthesis, characterization and determination of the action of structural elements].
Kertscher HP; Ostermann G; Findeisen M; Limmer S; Gawrisch K
Pharmazie; 1991 Aug; 46(8):575-9. PubMed ID: 1798710
[TBL] [Abstract][Full Text] [Related]
7. Biochemical characterization of the interaction of lipid phosphoric acids with human platelets: comparison with platelet activating factor.
Sugiura T; Tokumura A; Gregory L; Nouchi T; Weintraub ST; Hanahan DJ
Arch Biochem Biophys; 1994 Jun; 311(2):358-68. PubMed ID: 8203898
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis, and structure-activity relationship studies of novel 1-[(1-acyl-4-piperidyl)methyl]-1H-2- methylimidazo[4,5-c]pyridine derivatives as potent, orally active platelet-activating factor antagonists.
Carceller E; Merlos M; Giral M; Balsa D; García-Rafanell J; Forn J
J Med Chem; 1996 Jan; 39(2):487-93. PubMed ID: 8558517
[TBL] [Abstract][Full Text] [Related]
9. Structure-activity relationships in platelet-activating factor (PAF antagonists). 6. Synthesis and in vitro antagonistic activities of 2-substituted 5-oxotetrahydrofurans.
Favre E; Heymans F; Redeuilh C; Batt JP; Massicot F; Blavet N; Braquet P; Godfroid JJ
J Lipid Mediat; 1992 Feb; 5(1):23-40. PubMed ID: 1449553
[TBL] [Abstract][Full Text] [Related]
10. Structure-activity relationships in platelet-activating factor (PAF). 5. Synthesis and in vitro antagonistic activities of ketophosphonates.
Furno-de Winter A; Broquet C; Haelters JP; Massicot F; Sturtz G; Godfroid JJ
J Lipid Mediat; 1991; 3(3):289-300. PubMed ID: 1773030
[TBL] [Abstract][Full Text] [Related]
11. Isolation of a phospholipid inhibitor of platelet activating factor-induced activity from perfused rat liver: identification as phosphatidylglycerol.
Lekka M; Tokumura A; Tsuji H; Hanahan DJ
Arch Biochem Biophys; 1993 May; 302(2):380-4. PubMed ID: 8489242
[TBL] [Abstract][Full Text] [Related]
12. PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
Ostermann G; Hofmann B; Kertscher HP; Till U
J Lipid Mediat; 1990; 2(1):21-31. PubMed ID: 1966804
[TBL] [Abstract][Full Text] [Related]
13. A novel class of platelet activating factor (PAF) antagonists. I. Synthesis and structure-activity studies on PAF-sulfonamide isosteres.
Tsuri T; Haga N; Matsui T; Kamata S; Kakushi H; Uchida K
Chem Pharm Bull (Tokyo); 1992 Jan; 40(1):75-84. PubMed ID: 1605805
[TBL] [Abstract][Full Text] [Related]
14. [Synthesis and platelet aggregating activity of structural analogs of platelet-activating factor with a heterocyclic head group].
Kertscher HP; Ostermann G
Pharmazie; 1987 Nov; 42(11):713-5. PubMed ID: 3438334
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and evaluation of antiplatelet activity of trihydroxychalcone derivatives.
Zhao LM; Jin HS; Sun LP; Piao HR; Quan ZS
Bioorg Med Chem Lett; 2005 Nov; 15(22):5027-9. PubMed ID: 16169724
[TBL] [Abstract][Full Text] [Related]
16. 1,5-Benzodiazepines. X. Dialkylamino substituted 1,5-benzodiazepine and [1,2,4]triazolo [4,3-a][1,5] benzodiazepine derivatives with inhibitory activity on PAF-induced platelet aggregation.
Di Braccio M; Roma G; Grossi GC; Leoncini G; Maresca M
Farmaco; 1992 Jan; 47(1):77-90. PubMed ID: 1616579
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and biological evaluation of novel steroid-modified ether phospholipids.
Karantonis HC; Pitsinos EN; Antonopoulou S; Couladouros EA; Demopoulos CA
Chem Phys Lipids; 2005 Dec; 138(1-2):12-9. PubMed ID: 16202400
[TBL] [Abstract][Full Text] [Related]
18. Structure-activity relationship studies on chalcone derivatives: potent inhibition of platelet aggregation.
Ko HH; Hsieh HK; Liu CT; Lin HC; Teng CM; Lin CN
J Pharm Pharmacol; 2004 Oct; 56(10):1333-7. PubMed ID: 15482650
[TBL] [Abstract][Full Text] [Related]
19. Effect of specific antagonists on PAF-induced platelet aggregation and release of plasminogen activator.
Hofmann B; Ostermann G; Hoffmann A; Klöcking HP; Kertscher HP
Biomed Biochim Acta; 1988; 47(10-11):S157-60. PubMed ID: 3248103
[TBL] [Abstract][Full Text] [Related]
20. Proaggregatory and inhibitory effects of 2-O-ethyl analogues of platelet-activating factor (PAF) on human and rabbit platelets.
Hofmann B; Ostermann G; Kertscher HP; Till U
Thromb Res; 1988 Feb; 49(4):415-23. PubMed ID: 3381200
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]